-
701
L’impérialisme humanitaire de Michael Ignatieff : le cas d’un « liberal hawk »
Published 2007-09-01“…Michael Ignatieff, a former Harvard professor who is now active in Canadian politics, represents a school of thought which may be called humanitarian imperialism or liberal imperialism whose most famous representative in Europe is Bernard Kouchner. …”
Get full text
Article -
702
Two Seventeenth-Century Garden Views from the Royal Palace of Aranjuez
Published 2021-11-01Get full text
Article -
703
Kitap Tanıtımı: Arapların Gözüyle Bizans
Published 2018-06-01“… TemeliniHarvard Üniversitesi’nde savunulan bir doktora tezinin oluşturduğu bu çalışma,Bizans hakkındaki Arap-İslam görüşünün yüzyıllar boyunca süren savaş, temas vekarşılıklı alışveriş ile geçirdiği evrim sürecinin bölgesel-tarihsel gelişmelerbağlamında izini sürmektedir.Kitap Giriş, Bizans’la karşılaşma, Bizans’ın karşısındadurmak, İslam savunmada ve Yeni bir gerçeklik: Bizans’ı yenidenziyaret başlıkları altında dört ana bölüm ve Sonuç kısmındanoluşmaktadır. …”
Get full text
Article -
704
-
705
-
706
-
707
-
708
A multigene phylogeny toward a new phylogenetic classification of Leotiomycetes
Published 2019-06-01Get full text
Article -
709
-
710
-
711
-
712
The role of renal dual-energy computed tomography in exploring the gouty kidney: the RENODECT study
Published 2025-12-01Get full text
Article -
713
-
714
-
715
-
716
-
717
Optimization of TMS target engagement: current state and future perspectives
Published 2025-01-01Get full text
Article -
718
Travoprost Intracameral Implant in Eyes with Glaucoma or Ocular Hypertension: Early Short-Term Real-World Outcomes
Published 2025-01-01“…Savak Teymoorian, Jasmin Kaur Harvard Eye Associates, Laguna Hills, CA, USACorrespondence: Savak Teymoorian, Harvard Eye Associates, 23961 Calle de la Magdalena, Suite 300, Laguna Hills, California, 92653, USA, Tel +1 949-951-2020, Fax +1 949-356-1660, Email steymoorian@harvardeye.comPurpose: To assess real-world efficacy and safety of standalone travoprost intracameral implant (iDose TR) implantation by a US glaucoma surgeon in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).Methods: This non-randomized, retrospective, unmasked, consecutive case series included all cases of standalone iDose TR implantation from a single US glaucoma surgeon since the product’s approval by the US Food and Drug Administration (FDA) in December 2023. …”
Get full text
Article -
719
-
720